Spironolactone and risk of upper gastrointestinal events: Spironolactone may not be guilty [7]

British Medical Journal

Volumn 333, Issue 7566, 2006, Pages 500-

  Campbell, Eugene ^a   Shonde, Anthony ^a   Foley, Stephen ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SPIRONOLACTONE; ALDOSTERONE ANTAGONIST;

GASTROINTESTINAL HEMORRHAGE; HUMAN; LETTER; PRIORITY JOURNAL; RISK FACTOR; ULCER; CHEMICALLY INDUCED DISORDER; GASTROINTESTINAL DISEASE; NOTE;

ALDOSTERONE ANTAGONISTS; GASTROINTESTINAL DISEASES; HUMANS; SPIRONOLACTONE;

EID: 33748437981     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.333.7566.500-c     Document Type: Letter

References (1)

1. Verhamme K, Mosis G, Dieleman J, Stricker B, Sturkenboom M. Spironolactone and risk of upper gastrointestinal events: population based case-control study. BMJ 2006;333:330.